Intratumoral gene expression levels for the immunosuppressive enzyme, IDO1, is similar for individuals <65 and ≥65 with wild-type IDH status, and significantly decreased among mIDH GBM (Figure 7B,C) as was previously reported (Zhai et al., 2017). The gene discussed is IDO1; the disease is glioblastoma.